Aptose Biosciences Inc (APTO)
0.3952
0.00 (0.00%)
USD |
NASDAQ |
Sep 20, 16:00
0.399
0.00 (0.00%)
After-Hours: 18:22
Aptose Biosciences Enterprise Value: -1.086M for Sept. 19, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 19, 2024 | -1.086M |
| September 18, 2024 | -0.9414M |
| September 17, 2024 | -0.9993M |
| September 16, 2024 | -1.648M |
| September 13, 2024 | -1.562M |
| September 12, 2024 | -1.785M |
| September 11, 2024 | -1.648M |
| September 10, 2024 | -1.812M |
| September 09, 2024 | -2.013M |
| September 06, 2024 | -1.758M |
| September 05, 2024 | -1.477M |
| September 04, 2024 | -1.450M |
| September 03, 2024 | -0.954M |
| August 30, 2024 | -0.9776M |
| August 29, 2024 | -1.135M |
| August 28, 2024 | -0.9957M |
| August 27, 2024 | -1.267M |
| August 26, 2024 | -1.182M |
| August 23, 2024 | -1.068M |
| August 22, 2024 | -1.014M |
| August 21, 2024 | 0.0329M |
| August 20, 2024 | 0.4567M |
| August 19, 2024 | 0.4531M |
| August 16, 2024 | 0.7247M |
| August 15, 2024 | 0.4386M |
| Date | Value |
|---|---|
| August 14, 2024 | 0.3806M |
| August 13, 2024 | 0.272M |
| August 12, 2024 | 0.2194M |
| August 09, 2024 | 0.9637M |
| August 08, 2024 | 1.721M |
| August 07, 2024 | 0.7066M |
| August 06, 2024 | -0.054M |
| August 05, 2024 | -0.8327M |
| August 02, 2024 | 0.5255M |
| August 01, 2024 | 1.145M |
| July 31, 2024 | 1.936M |
| July 30, 2024 | 1.980M |
| July 29, 2024 | 1.938M |
| July 26, 2024 | 1.956M |
| July 25, 2024 | 1.963M |
| July 24, 2024 | 2.735M |
| July 23, 2024 | 2.804M |
| July 22, 2024 | 2.887M |
| July 19, 2024 | 3.622M |
| July 18, 2024 | 3.532M |
| July 17, 2024 | 3.713M |
| July 16, 2024 | 3.840M |
| July 15, 2024 | 4.401M |
| July 12, 2024 | 4.528M |
| July 11, 2024 | 4.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-15.17M
Minimum
Dec 27 2022
587.38M
Maximum
Feb 20 2020
134.57M
Average
32.45M
Median
Jan 21 2022
Enterprise Value Benchmarks
| Acasti Pharma Inc | 9.794M |
| Aurinia Pharmaceuticals Inc | 699.06M |
| Edesa Biotech Inc | 12.09M |
| Lexaria Bioscience Corp | 40.92M |
| Xenon Pharmaceuticals Inc | 2.379B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.252M |
| Total Expenses (Quarterly) | 7.345M |
| EPS Diluted (Quarterly) | -0.43 |
| Earnings Yield | -1.10K% |